WEREWOLF THERAPEUTICS INC HOWL
COM · Common Stock · CUSIP 95075A107
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersWaltham, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 29.5m as of 2022-08-05, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $4.09. Options: 2 managers hold calls ($1.0k notional), 2 hold puts ($0).
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2021 | 46 |
| Q3 2021 | 43 |
| Q4 2021 | 52 |
| Q1 2022 | 50 |
| Q2 2022 | 47 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2021 | 17 | 17 |
| Q4 2021 | 31 | 9 |
| Q1 2022 | 21 | 23 |
| Q2 2022 | 21 | 31 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2021 | $0 | $0 | — |
| Q4 2021 | $0 | $0 | — |
| Q1 2022 | $0 | $0 | — |
| Q2 2022 | $1.0k | $0 | 0.00 |
Biggest buyers
| PFM Health Sciences, LP | Added | +1.1m |
| Laurion Capital Management LP | New | +535.2k |
| Oasis Management Co Ltd. | New | +246.3k |
| MILLENNIUM MANAGEMENT LLC | Added | +206.5k |
| Rubric Capital Management LP | New | +205.0k |
| Ergoteles LLC | New | +129.0k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | New | +36.2k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Added | +25.0k |
| Qube Research & Technologies Ltd | New | +22.5k |
| BAILARD, INC. | New | +21.2k |
Biggest sellers
| BlackRock Inc. | Reduced | -1.1m |
| STATE STREET CORP | Reduced | -310.5k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -209.0k |
| Migdal Insurance & Financial Holdings Ltd. | Sold out | -187.5k |
| NORTHERN TRUST CORP | Reduced | -181.2k |
| VANGUARD GROUP INC | Reduced | -126.0k |
| Bank of New York Mellon Corp | Sold out | -68.3k |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Sold out | -60.6k |
| Granite Point Capital Management, L.P. | Sold out | -55.0k |
| Evercore Wealth Management, LLC | Sold out | -46.5k |
Biggest calls
| SIMPLEX TRADING, LLC | New | $1.0k300 shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
| SIMPLEX TRADING, LLC | New | $0100 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| MOLL PETER 13G · exempt (held before listing) new · filed 2026-09-21 | 5.2% |
Fell to 5% or below in the last year: RA CAPITAL MANAGEMENT, L.P. (4.1%, 2026-07-02), MPM BioVentures 2014, L.P. (3.8%, 2026-05-12), Longwood Fund III, L.P. (3.5%, 2026-02-11)
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 4 | $45.4m | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 1 | $40.2k | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
None reported in Q2 2022.
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 0.47% of their portfolio | 4.3m $17.6m | Unchanged |
| MPM ASSET MANAGEMENT LLC 7.39% of their portfolio | 4.3m $17.5m | Unchanged |
| MPM BIOIMPACT LLC 2.71% of their portfolio | 2.4m $9.8m | Unchanged |
| PFM Health Sciences, LP 0.28% of their portfolio | 1.7m $7.1m | Added +1.1m |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.01% of their portfolio | 1.0m $4.1m | Added +25.0k |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.08% of their portfolio | 958.1k $3.9m | Unchanged |
| SPHERA FUNDS MANAGEMENT LTD. 0.46% of their portfolio | 597.0k $2.4m | Added +12.8k |
| DC Funds, LP 33.24% of their portfolio | 589.1k $2.4m | Unchanged |
| Laurion Capital Management LP 0.09% of their portfolio | 535.2k $2.2m | New |
| FMR LLC 0.00% of their portfolio | 518.8k $2.1m | Added +137 |
| VANGUARD GROUP INC 0.00% of their portfolio | 396.1k $1.6m | Reduced -126.0k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 248.9k $1.0m | Added +206.5k |
| Oasis Management Co Ltd. 0.18% of their portfolio | 246.3k $1.0m | New |
| PLATINUM INVESTMENT MANAGEMENT LTD 0.03% of their portfolio | 213.4k $873.0k | Unchanged |
| Alyeska Investment Group, L.P. 0.01% of their portfolio | 206.2k $843.0k | Unchanged |
| Rubric Capital Management LP 0.04% of their portfolio | 205.0k $838.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 184.0k $752.0k | Reduced -1.1m |
| Ergoteles LLC 0.02% of their portfolio | 129.0k $528.0k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 79.3k $324.0k | Reduced -209.0k |
| CAAS CAPITAL MANAGEMENT LP 0.03% of their portfolio | 62.6k $256.0k | Reduced -39.0k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 36.2k $148.0k | New |
| STATE STREET CORP 0.00% of their portfolio | 24.6k $100.0k | Reduced -310.5k |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 22.5k $92.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 22.3k $91.0k | Added +14.7k |
| BAILARD, INC. 0.00% of their portfolio | 21.2k $87.0k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 16.8k $69.0k | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 13.8k $57.0k | Reduced -181.2k |
| Cubist Systematic Strategies, LLC 0.00% of their portfolio | 13.2k $54.0k | New |
| Y-Intercept (Hong Kong) Ltd 0.01% of their portfolio | 11.1k $45.0k | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 11.0k $45.0k | Reduced -672 |
| UBS Group AG 0.00% of their portfolio | 4.3k $18.0k | Added +2.2k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 3.7k $15.0k | Reduced -11.9k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 2.7k $11.0k | Reduced -19.6k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 2.3k $10.0k | Reduced -374 |
| CITIGROUP INC 0.00% of their portfolio | 736 $3.0k | Reduced -1.9k |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP 0.00% of their portfolio | 580 $2.0k | Unchanged |
| Financial Perspectives, Inc 0.00% of their portfolio | 250 $1.0k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 233 $1.0k | Reduced -1.4k |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 187 $1.0k | Reduced -13.9k |
| BARCLAYS PLC 0.00% of their portfolio | 108 $0 | Reduced -4.2k |
| Daiwa Securities Group Inc. 0.00% of their portfolio | 80 $0 | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 50 $0 | Reduced -5.7k |
| Ellevest, Inc. 0.00% of their portfolio | 31 $0 | New |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 15 $0 | New |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 14 $0 | New |
| Glassman Wealth Services 0.00% of their portfolio | 5 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |